What is the survival rate associated with Dukes C staging?

Dukes C staging refers to a specific categorization of colorectal cancer, where the cancer has invaded through the muscularis propria and into surrounding tissues, with lymph node involvement but no distant metastasis. This stage reflects a significant progression of the disease, and as such, the prognosis is more serious compared to earlier stages.

The survival rate associated with Dukes C staging is approximately 60%. This figure takes into account various patient factors, treatment responsiveness, and overall advancements in medical therapies. This survival rate indicates that while there is a concerning risk involved with this stage of cancer, many patients do still survive for five years or more post-diagnosis with appropriate treatment, which may include surgery, chemotherapy, or radiation.

The other percentages provided in the options do not align with known survival statistics for Dukes C. A survival rate of 95% would suggest a very favorable prognosis typical of early-stage disease, while 80% is more aligned with Dukes B. A 25% survival rate would indicate a much poorer prognosis more commonly associated with advanced disease, such as distant metastasis found in Dukes D stage. Thus, the 60% rate accurately reflects the implications of Dukes C staging within colorectal cancer management.